drugset / Trial / NCT01270412

Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis PRP as a Treatment for Knee Osteoarthritis

NCT01270412

Phase 2/3 Unknown 100 enrolled Meir Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

Autologous platelet-secreted growth factors (GFs) may have therapeutic effects in osteoarthritis (OA) capsular joints via multiple mechanisms. The aim is to examine the effect of a platelet-derived preparation rich in growth factors (PRGFs) in OA of the knee.

Timeline

Start
2011-09
Primary completion
2012-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hyaluronic Acid Other / unclassified 20 mg Other
Subject Platelet Rich Plasma Other / unclassified 6 ml Other

Indications